The estimated Net Worth of Alfonso G Zulueta is at least $18.5 Milion dollars as of 1 February 2021. Mr. Zulueta owns over 16,754 units of CTS stock worth over $1,622,382 and over the last 11 years he sold CTS stock worth over $16,685,198. In addition, he makes $182,364 as Independent Director at CTS.
Alfonso has made over 27 trades of the CTS stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 16,754 units of CTS stock worth $767,836 on 1 February 2021.
The largest trade he's ever made was exercising 21,302 units of CTS stock on 7 November 2014 worth over $1,185,456. On average, Alfonso trades about 5,526 units every 48 days since 2014. As of 1 February 2021 he still owns at least 35,400 units of CTS stock.
You can see the complete history of Mr. Zulueta stock trades at the bottom of the page.
Alfonso G. Zulueta serves as Independent Director of the Company. Mr. Zulueta is Senior Vice President of Eli Lilly and Company since 2014. He is President of Lilly International (2017 - Present). He is Member of the Executive Committee and Officer of Eli Lilly and Company (2017 - Present). He was the President of Emerging Markets and various roles of Eli Lilly and Company (1988 - 2014). Mr. Zulueta holds a bachelor's degree in economics from De La Salle University in the Philippines and an MBA from the University of Virginia. He currently serves as a director on the board of the European Federation of Pharmaceutical Industries and Associations.
As the Independent Director of CTS, the total compensation of Alfonso Zulueta at CTS is $182,364. There are 7 executives at CTS getting paid more, with Kieran O'Sullivan having the highest compensation of $2,438,240.
Alfonso Zulueta is 57, he's been the Independent Director of CTS since 2018. There are 4 older and 4 younger executives at CTS. The oldest executive at CTS Corp. is Robert Profusek, 70, who is the Lead Independent Director.
Alfonso's mailing address filed with the SEC is 4925 INDIANA AVENUE, , LISLE, IL, 60532.
Over the last 21 years, insiders at CTS have traded over $11,582,788 worth of CTS stock and bought 97,128 units worth $484,822 . The most active insiders traders include William S Johnson, Gordon Hunter oraz Patricia K Collawn. On average, CTS executives and independent directors trade stock every 76 days with the average trade being worth of $276,172. The most recent stock trade was executed by Martin Baumeister on 24 May 2024, trading 5,733 units of CTS stock currently worth $300,352.
cts (nyse: cts) is a designer and manufacturer of sensors, actuators and electronic components for original equipment manufacturers (oems) in the aerospace, communications, defense, industrial, information technology, medical and transportation markets. cts aims to be a leading provider of sensing and motion devices as well as connectivity components, enabling an intelligent and seamless world. this is accomplished by maintaining a strategy of investing in innovative products that fulfil the cts value proposition - sense, connect and move. cts manufactures products in north america, europe and asia.
CTS executives and other stock owners filed with the SEC include: